Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,070 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The protective gene dose effect of the APOE ε2 allele on gray matter volume in cognitively unimpaired individuals.
Salvadó G, Ferreira D, Operto G, Cumplido-Mayoral I, Arenaza-Urquijo EM, Cacciaglia R, Falcon C, Vilor-Tejedor N, Minguillon C, Groot C, van der Flier WM, Barkhof F, Scheltens P, Ossenkoppele R, Kern S, Zettergren A, Skoog I, Hort J, Stomrud E, van Westen D, Hansson O, Molinuevo JL, Wahlund LO, Westman E, Gispert JD; ALFA study†, BioFINDER, ADNI. Salvadó G, et al. Among authors: ferreira d. Alzheimers Dement. 2022 Jul;18(7):1383-1395. doi: 10.1002/alz.12487. Epub 2021 Dec 8. Alzheimers Dement. 2022. PMID: 34877786 Free PMC article.
Cognitive decline is mediated by gray matter changes during middle age.
Ferreira D, Molina Y, Machado A, Westman E, Wahlund LO, Nieto A, Correia R, Junqué C, Díaz-Flores L, Barroso J. Ferreira D, et al. Neurobiol Aging. 2014 May;35(5):1086-94. doi: 10.1016/j.neurobiolaging.2013.10.095. Epub 2013 Oct 29. Neurobiol Aging. 2014. PMID: 24239436
Improving CSF Biomarkers' Performance for Predicting Progression from Mild Cognitive Impairment to Alzheimer's Disease by Considering Different Confounding Factors: A Meta-Analysis.
Ferreira D, Rivero-Santana A, Perestelo-Pérez L, Westman E, Wahlund LO, Sarría A, Serrano-Aguilar P. Ferreira D, et al. Front Aging Neurosci. 2014 Oct 16;6:287. doi: 10.3389/fnagi.2014.00287. eCollection 2014. Front Aging Neurosci. 2014. PMID: 25360114 Free PMC article. Review.
Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease.
Karami A, Eyjolfsdottir H, Vijayaraghavan S, Lind G, Almqvist P, Kadir A, Linderoth B, Andreasen N, Blennow K, Wall A, Westman E, Ferreira D, Kristoffersen Wiberg M, Wahlund LO, Seiger Å, Nordberg A, Wahlberg L, Darreh-Shori T, Eriksdotter M. Karami A, et al. Among authors: ferreira d. Alzheimers Dement. 2015 Nov;11(11):1316-28. doi: 10.1016/j.jalz.2014.11.008. Epub 2015 Feb 9. Alzheimers Dement. 2015. PMID: 25676388
Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment.
Ferreira D, Cavallin L, Larsson EM, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Simmons A, Wahlund LO, Westman E; AddNeuroMed consortium and the Alzheimer's Disease Neuroimaging Initiative. Ferreira D, et al. J Intern Med. 2015 Sep;278(3):277-90. doi: 10.1111/joim.12358. Epub 2015 Apr 13. J Intern Med. 2015. PMID: 25752192 Free article.
The Effect of Age Correction on Multivariate Classification in Alzheimer's Disease, with a Focus on the Characteristics of Incorrectly and Correctly Classified Subjects.
Falahati F, Ferreira D, Soininen H, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Lovestone S, Eriksdotter M, Wahlund LO, Simmons A, Westman E; AddNeuroMed consortium and the Alzheimer’s Disease Neuroimaging Initiative. Falahati F, et al. Among authors: ferreira d. Brain Topogr. 2016 Mar;29(2):296-307. doi: 10.1007/s10548-015-0455-1. Epub 2015 Oct 6. Brain Topogr. 2016. PMID: 26440606 Free PMC article.
2,070 results